Sunil Healthcare Ltd
Incorporated in 1976, Sunil Healthcare Ltd is a manufacturer of Empty Hard Gelatin, HPMC Capsule Shells & Ayurvedic Medicines[1]
- Market Cap ₹ 59.9 Cr.
- Current Price ₹ 58.4
- High / Low ₹ 88.7 / 58.4
- Stock P/E 33.8
- Book Value ₹ 72.6
- Dividend Yield 0.00 %
- ROCE 4.93 %
- ROE 0.39 %
- Face Value ₹ 10.0
Pros
- Stock is trading at 0.81 times its book value
Cons
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of 3.53% over past five years.
- Company has a low return on equity of 2.63% over last 3 years.
- Company has high debtors of 212 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 61.66 | 72.64 | 81.63 | 108.95 | 90.22 | 80.93 | 70.13 | 89.89 | 116.37 | 111.83 | 89.69 | 83.42 | 89.20 | |
| 50.35 | 60.57 | 66.75 | 93.21 | 75.52 | 68.45 | 76.58 | 83.68 | 98.55 | 92.52 | 85.24 | 71.45 | 75.45 | |
| Operating Profit | 11.31 | 12.07 | 14.88 | 15.74 | 14.70 | 12.48 | -6.45 | 6.21 | 17.82 | 19.31 | 4.45 | 11.97 | 13.75 |
| OPM % | 18.34% | 16.62% | 18.23% | 14.45% | 16.29% | 15.42% | -9.20% | 6.91% | 15.31% | 17.27% | 4.96% | 14.35% | 15.41% |
| 0.38 | 0.94 | 1.33 | 1.25 | 2.00 | 0.09 | 14.71 | 5.56 | 1.55 | 1.63 | 4.53 | 1.25 | 1.29 | |
| Interest | 2.48 | 2.85 | 4.36 | 4.18 | 5.03 | 6.58 | 6.95 | 5.31 | 3.49 | 4.17 | 5.78 | 6.46 | 6.06 |
| Depreciation | 4.09 | 4.00 | 3.82 | 4.33 | 4.78 | 5.74 | 6.13 | 6.11 | 6.31 | 7.01 | 6.08 | 6.35 | 6.60 |
| Profit before tax | 5.12 | 6.16 | 8.03 | 8.48 | 6.89 | 0.25 | -4.82 | 0.35 | 9.57 | 9.76 | -2.88 | 0.41 | 2.38 |
| Tax % | 35.94% | 35.39% | 34.99% | 33.73% | 22.64% | 28.00% | -13.49% | 22.86% | 29.15% | 28.48% | -27.08% | 48.78% | |
| 3.28 | 3.98 | 5.23 | 5.62 | 5.32 | 0.18 | -4.17 | 0.28 | 6.78 | 6.98 | -2.11 | 0.21 | 1.77 | |
| EPS in Rs | 3.20 | 3.88 | 5.10 | 5.48 | 5.19 | 0.18 | -4.07 | 0.27 | 6.61 | 6.81 | -2.06 | 0.20 | 1.72 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 1% |
| 5 Years: | 4% |
| 3 Years: | -11% |
| TTM: | 7% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -23% |
| 5 Years: | 16% |
| 3 Years: | -65% |
| TTM: | 17800% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | -6% |
| 5 Years: | 21% |
| 3 Years: | 1% |
| 1 Year: | -15% |
| Return on Equity | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 4% |
| 3 Years: | 3% |
| Last Year: | 0% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 10.25 | 10.25 | 10.25 | 10.25 | 10.25 | 10.25 | 10.25 | 10.25 | 10.25 | 10.25 | 10.25 | 10.25 | 10.25 |
| Reserves | 12.87 | 15.62 | 20.81 | 33.24 | 38.54 | 38.88 | 37.52 | 37.82 | 44.53 | 51.47 | 63.79 | 63.40 | 64.22 |
| 19.94 | 25.16 | 37.06 | 44.53 | 60.62 | 55.08 | 49.45 | 49.82 | 34.68 | 36.79 | 66.15 | 68.65 | 60.00 | |
| 12.59 | 12.51 | 17.66 | 31.33 | 33.18 | 35.50 | 37.19 | 25.68 | 22.73 | 27.57 | 23.70 | 25.91 | 30.79 | |
| Total Liabilities | 55.65 | 63.54 | 85.78 | 119.35 | 142.59 | 139.71 | 134.41 | 123.57 | 112.19 | 126.08 | 163.89 | 168.21 | 165.26 |
| 27.02 | 27.31 | 40.94 | 59.72 | 70.92 | 68.82 | 69.97 | 69.80 | 69.97 | 70.43 | 87.16 | 94.08 | 92.52 | |
| CWIP | 0.26 | 0.77 | 0.06 | 0.12 | 0.19 | 2.47 | 0.01 | 0.01 | 1.75 | 0.01 | 5.66 | 0.09 | 0.18 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.23 | 0.24 | 0.24 | 1.20 | 1.16 | 0.00 | 0.00 | 0.00 | 0.10 |
| 28.37 | 35.46 | 44.78 | 59.51 | 71.25 | 68.18 | 64.19 | 52.56 | 39.31 | 55.64 | 71.07 | 74.04 | 72.46 | |
| Total Assets | 55.65 | 63.54 | 85.78 | 119.35 | 142.59 | 139.71 | 134.41 | 123.57 | 112.19 | 126.08 | 163.89 | 168.21 | 165.26 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 8.18 | 5.88 | 7.77 | 10.79 | 4.91 | 15.07 | 4.18 | 16.63 | 21.89 | 7.13 | -14.35 | 11.54 | |
| -2.72 | -8.48 | -14.90 | -12.85 | -17.36 | -3.08 | -2.46 | -11.33 | -3.35 | -3.40 | -10.62 | -7.70 | |
| -5.00 | 2.75 | 8.18 | 2.23 | 11.62 | -11.66 | -1.54 | -6.42 | -18.56 | -3.75 | 25.00 | -3.87 | |
| Net Cash Flow | 0.46 | 0.15 | 1.05 | 0.17 | -0.83 | 0.33 | 0.18 | -1.12 | -0.01 | -0.02 | 0.04 | -0.03 |
| Free Cash Flow | 5.23 | -1.93 | -6.69 | -2.15 | -10.75 | 9.56 | 3.50 | 9.92 | 12.87 | 3.65 | -24.53 | 2.54 |
| CFO/OP | 80% | 75% | 65% | 79% | 43% | 123% | -66% | 265% | 129% | 44% | -305% | 96% |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 100.04 | 99.39 | 107.94 | 130.49 | 194.11 | 186.63 | 149.01 | 112.84 | 69.00 | 115.90 | 192.37 | 212.21 |
| Inventory Days | 132.12 | 109.32 | 134.28 | 74.03 | 98.26 | 185.09 | 283.19 | 95.96 | 76.84 | 97.03 | 98.42 | 162.94 |
| Days Payable | 107.06 | 80.62 | 106.03 | 137.66 | 180.38 | 280.22 | 297.33 | 107.97 | 64.07 | 112.06 | 44.74 | 83.51 |
| Cash Conversion Cycle | 125.10 | 128.09 | 136.18 | 66.86 | 111.99 | 91.50 | 134.87 | 100.83 | 81.77 | 100.87 | 246.04 | 291.63 |
| Working Capital Days | 1.42 | 6.93 | -6.57 | -9.65 | -11.00 | -40.23 | -46.79 | -34.72 | -11.07 | 16.25 | 30.24 | 26.38 |
| ROCE % | 18.13% | 19.19% | 20.80% | 16.37% | 12.08% | 6.39% | 2.38% | 5.84% | 13.88% | 14.73% | 2.57% | 4.93% |
Insights
In beta| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Installed Capacity Billion Capsules per annum |
|
|||||||||||
| Capacity Utilization % |
||||||||||||
| Production Volume Million Capsules |
||||||||||||
| Sales Volume Million Capsules |
||||||||||||
| Number of Capsule Sizes (SKUs) Count |
||||||||||||
Documents
Announcements
- Closure of Trading Window 27 Mar
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
8 Feb - Newspaper clippings regarding publication of un-audited financial results for 3rd quarter/9 months ended 31st December 2025 (both standalone and consolidated)
-
Board Meeting Outcome for Outcome Of The Board Meeting Held On 06.02.2026
6 Feb - Board approved unaudited standalone and consolidated Q3/9M results for period ended Dec 31, 2025; limited review attached.
-
Unaudited Financial Results (Both Standalone And Consolidated) For The Quarter And Nine Months Ended 31.12.2025 Of FY 2025-26
6 Feb - Board approved unaudited standalone and consolidated Q3/9M results ended December 31, 2025; limited review enclosed.
-
Board Meeting Intimation for Intimation Of Board Meeting Pursuant To Regulation 29 Of SEBI (LODR) Regulations, 2015
28 Jan - Board meeting Feb 06, 2026 to approve Q3/9M unaudited results for period ended Dec 31, 2025.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Concalls
-
Nov 2018TranscriptAI SummaryPPT
-
Sep 2018TranscriptAI SummaryPPT
-
May 2018TranscriptAI SummaryPPT
-
May 2018TranscriptAI SummaryPPT
-
Feb 2018TranscriptAI SummaryPPT
-
Feb 2018TranscriptAI SummaryPPT
-
Dec 2017TranscriptAI SummaryPPT
-
Aug 2017TranscriptAI SummaryPPT
-
May 2017TranscriptAI SummaryPPT
-
Feb 2017TranscriptAI SummaryPPT
-
Nov 2016TranscriptAI SummaryPPT
-
Aug 2016TranscriptAI SummaryPPT
-
May 2016TranscriptAI SummaryPPT
-
Mar 2016TranscriptAI SummaryPPT
Business Overview:[1]
Company is the second-largest manufacturer of Empty Hard Shell Gelatin Capsules in India which its sells under the brand name Sunloc. Company does production of double lock, triple lock, multiple groove capsules of EHGC & some proportion of vegan HPMC (Hydroxy Propyl Methyl Cellulose) along with liner, circular, two color printing & 360degree printing being offered